Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer

The Prostate(2025)10.1002/pros.70006Source: DataRank Database

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer is a research paper published in The Prostate (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Andrew M. Asberry ORCID,Xuehong Deng,Sheng Liu ORCID,Jiaoti Huang ORCID,Chang‐Deng Hu ORCID

Live enrichment

PubMed:40677010 PMC:PMC12329194 OpenAlex:https://openalex.org/W4412492652

NCI NIH HHS

Grant: P30 CA023168

NCI NIH HHS

Grant: P30 CA082709

Purdue University Center for Cancer Research

This study was supported by Purdue University Center for Cancer Research and DOD Prostate Cancer Research Program.

FWCI

0.00

Citation Percentile

0.1%

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pros.70006

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pros.70006

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.70006

journalhttps://doi.org/10.1002/pros.70006

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40677010

Fields of Study

Cancer-related gene regulationAxon Guidance and Neuronal SignalingProstate Cancer Treatment and ResearchMaleProtein-Arginine N-MethyltransferasesAnimalsHumansMiceBenzamidesProstatic Neoplasms, Castration-ResistantNitrilesPhenylthiohydantoinCell Line, TumorCell DifferentiationProstatic NeoplasmsCarcinoma, NeuroendocrineNeuroendocrine CellsAdaptor Proteins, Signal TransducingTranscription Factors

MeSH Terms

AnimalsBenzamidesCell DifferentiationHumansMaleNitrilesPhenylthiohydantoinProstatic NeoplasmsProtein-Arginine N-MethyltransferasesTranscription FactorsCarcinoma, NeuroendocrineCell Line, TumorAdaptor Proteins, Signal TransducingMiceNeuroendocrine CellsProstatic Neoplasms, Castration-Resistant

Keywords

Prostate cancerProtein arginine methyltransferase 5EnzalutamideCancer researchProstateNeuroendocrine differentiationPCA3LNCaPAndrogen receptorBiologyMedicineCancerPathologyInternal medicineMethyltransferaseGeneDrug resistanceNeuroendocrinePrmt5

Sustainable Development Goals

SDG 0: Good health and well-being